Recombinant Human GRK3 Protein: Preparation & Usage Protocol

Recombinant Human GRK3 Protein is a purified serine/threonine kinase used in GPCR desensitization research, kinase activity assays, and drug-target interaction studies, providing researchers with a reliable, ready-to-use tool for dissecting β-adrenergic and broader GPCR signaling pathways.

Product Name

Recombinant Human GRK3 Protein

SKU

rp370610

Protein Family

G Protein-Coupled Receptor Kinase (GRK) family, AGC kinase superfamily

Also Known As

ADRBK2, Beta-adrenergic receptor kinase 2 (BARK2)

Function

Phosphorylates activated GPCRs to initiate receptor desensitization and internalization

Recommended Storage

Store at -80 °C; avoid repeated freeze-thaw cycles

Application Areas

Kinase activity assays, GPCR signaling studies, drug discovery, protein interaction studies

Overview of GRK3 Biology and Significance

G protein-coupled receptor kinase 3 (GRK3), also known as ADRBK2 or Beta-adrenergic receptor kinase 2 (BARK2), is a member of the GRK subfamily within the AGC kinase superfamily. GRK3 is a serine/threonine kinase that selectively phosphorylates the intracellular domains of agonist-occupied (activated) G protein-coupled receptors (GPCRs), a process that is a critical first step in receptor desensitization.

Upon phosphorylation by GRK3, receptors acquire high affinity for arrestin proteins, which sterically uncouple the receptor from its cognate G proteins and facilitate receptor internalization via clathrin-coated pits. This regulatory mechanism controls the intensity and duration of GPCR-mediated cellular responses. GRK3 is broadly expressed across multiple tissues and has been implicated in cardiovascular regulation, neurological function, and inflammatory signaling. Its dysregulation has been associated with heart failure, neuropsychiatric disorders, and cancer, making it a significant target for therapeutic investigation.

Reagent Reconstitution and Preparation

Proper reconstitution is essential to preserve the activity and integrity of Recombinant Human GRK3 Protein. Follow these steps carefully before use:

1. Equilibrate to appropriate temperature: Remove the vial from -80 °C storage and allow it to equilibrate briefly on ice (do not thaw at room temperature) to minimize protein denaturation.
2. Centrifuge before opening: Briefly centrifuge the vial (e.g., 5–10 seconds at low speed) to collect any lyophilized material or condensate from the lid and walls of the vial.
3. Reconstitution buffer: Reconstitute the protein in sterile, high-quality water or in the buffer recommended in the product datasheet (typically a phosphate-buffered saline containing a carrier protein such as 0.1% BSA or glycerol to stabilize the protein). Consult the specific product Certificate of Analysis (CoA) for exact recommendations.
4. Gentle mixing: Mix gently by pipetting or by very gentle swirling. Do NOT vortex, as vigorous agitation can denature or aggregate the protein.
5. Prepare aliquots: Immediately after reconstitution, divide the solution into single-use aliquots to avoid repeated freeze-thaw cycles, which significantly reduce kinase activity.
6. Concentration verification: If required, determine protein concentration by a suitable method (e.g., BCA or Bradford assay) or use the concentration stated in the CoA.

Note: All handling should be performed on ice or in a cold environment to maximize protein stability.

Kinase Activity Assay Protocol

Recombinant Human GRK3 Protein can be used in in vitro kinase activity assays to characterize its enzymatic function or to screen inhibitors and activators. A general radioactive or non-radioactive kinase assay protocol is outlined below:

Materials Required

• Recombinant Human GRK3 Protein (rp370610)
• Kinase assay buffer (e.g., 20 mM HEPES pH 7.4, 10 mM MgCl₂, 1 mM DTT)
• ATP (cold) or [γ-³²P]-ATP for radioactive detection
• Substrate peptide or purified GPCR substrate protein
• Stop solution (e.g., SDS loading buffer or EDTA)
• P81 phosphocellulose paper (for radioactive format) or relevant ELISA/antibody-based detection reagents (for non-radioactive format)

Procedure

1. Prepare the kinase reaction mixture on ice: combine kinase assay buffer, GRK3 protein, substrate, and ATP to the desired final concentrations. Refer to the product datasheet for recommended enzyme and substrate concentrations.
2. Initiate the reaction by adding ATP. Incubate at 30 °C for the desired reaction time (typically 30–60 minutes).
3. Stop the reaction by adding stop solution or by transferring to ice and adding EDTA.
4. For radioactive detection: spot reaction onto P81 paper, wash extensively with 0.75% phosphoric acid, dry, and quantify by scintillation counting.
5. For non-radioactive detection: use a phospho-specific antibody or luminescence-based ADP detection kit according to the manufacturer's instructions.
6. Calculate kinase activity from the signal obtained relative to a no-enzyme control.

Optimization of enzyme concentration, substrate concentration, and reaction time may be necessary depending on the specific experimental context.

Storage, Stability, and Quality Control

Maintaining the stability and activity of Recombinant Human GRK3 Protein requires strict adherence to proper storage and handling conditions.

Storage Conditions

• Long-term storage: Store at -80 °C in single-use aliquots. Do not store working stocks at -20 °C for extended periods.
• Short-term storage: If the protein will be used within 1–2 weeks, it may be stored at 4 °C; however, long-term storage at 4 °C is not recommended as it may lead to loss of activity.
• Avoid freeze-thaw cycles: Each freeze-thaw cycle can cause protein aggregation and loss of enzymatic activity. Always use pre-made single-use aliquots.

Stability

Recombinant kinase proteins are generally sensitive to temperature fluctuations, proteolytic degradation, and oxidation. The inclusion of protease inhibitors and reducing agents (e.g., DTT) in working buffers is recommended. Check the product-specific CoA for guaranteed stability data.

Quality Control

Each lot of Recombinant Human GRK3 Protein from Aladdin Scientific is subject to quality control testing, which typically includes SDS-PAGE purity assessment and functional kinase activity verification. Refer to the lot-specific CoA available upon request for purity, activity, and endotoxin data.

Troubleshooting and Best Practices

The following troubleshooting guide addresses common issues encountered when working with Recombinant Human GRK3 Protein:

Problem	Possible Cause	Recommended Solution
Low or no kinase activity	Protein degradation due to improper storage or repeated freeze-thaw	Use freshly thawed, single-use aliquots stored at -80 °C; keep protein on ice at all times during use
High background signal	Non-specific phosphorylation or contaminating kinase activity	Include a no-enzyme control; verify substrate specificity; check buffer components for contaminating ATP
Protein precipitation or aggregation	Rapid thawing, vortexing, or incompatible buffer	Thaw on ice slowly; avoid vortexing; ensure buffer compatibility and include stabilizing agents (BSA, glycerol)
Inconsistent results between experiments	Variability in protein concentration or assay conditions	Normalize protein input using accurate quantification (BCA/Bradford); standardize all assay conditions and timings

Best practices summary: Always keep the protein cold, minimize handling time, use high-quality reagents, and include appropriate positive and negative controls in every experiment to validate results.

Frequently asked questions

What is GRK3 and why is it important in signaling research?

GRK3 (G protein-coupled receptor kinase 3, also known as ADRBK2 or BARK2) is a serine/threonine kinase that phosphorylates agonist-activated GPCRs, initiating receptor desensitization and internalization. It plays critical roles in regulating the duration and magnitude of GPCR-mediated signals across cardiovascular, neurological, and immune systems. Dysregulation of GRK3 has been linked to heart failure, neuropsychiatric diseases, and oncology, making it an important target for fundamental and translational research.

How should I store Recombinant Human GRK3 Protein to maintain its activity?

Store Recombinant Human GRK3 Protein at -80 °C in single-use aliquots immediately after reconstitution. Avoid repeated freeze-thaw cycles, as these significantly reduce enzymatic activity through protein aggregation and denaturation. If using the protein within one to two weeks, short-term storage at 4 °C is acceptable, but long-term storage at this temperature is not recommended. Always keep the protein on ice during experimental handling.

What substrates and buffers are recommended for GRK3 kinase activity assays?

GRK3 kinase assays are typically performed in a buffer containing 20 mM HEPES (pH 7.4), 10 mM MgCl₂, and 1 mM DTT, supplemented with ATP. Suitable substrates include GPCR-derived peptides or purified GPCR proteins that serve as physiological phosphorylation targets. Consult the product-specific datasheet and Certificate of Analysis for validated substrate and reaction condition recommendations, as optimal conditions may vary by lot and application.

Can Recombinant Human GRK3 Protein be used for inhibitor screening?

Yes, Recombinant Human GRK3 Protein is suitable for in vitro inhibitor screening assays. The purified, active kinase can be incorporated into standard kinase inhibitor screening formats, including radioactive filter-binding assays, fluorescence polarization assays, or luminescence-based ADP detection assays. Appropriate positive controls (known GRK3 inhibitors, if available) and negative controls (no-enzyme or no-ATP reactions) should always be included to validate screening results.

What quality control tests are performed on Recombinant Human GRK3 Protein?

Each lot of Recombinant Human GRK3 Protein from Aladdin Scientific undergoes quality control testing that typically includes SDS-PAGE analysis for purity assessment and functional kinase activity verification. Endotoxin testing may also be performed. Lot-specific Certificates of Analysis are available upon request and contain detailed purity, activity, and formulation data to support your experimental planning.

References

1. Pitcher JA, Freedman NJ, Lefkowitz RJ. G protein-coupled receptor kinases. Annu Rev Biochem. 1998;67:653-692. doi:10.1146/annurev.biochem.67.1.653
2. Kohout TA, Lefkowitz RJ. Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol Pharmacol. 2003;63(1):9-18. doi:10.1124/mol.63.1.9
3. Ribas C, Penela P, Murga C, et al. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta. 2007;1768(4):913-922. doi:10.1016/j.bbamem.2006.09.019

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.